294 related articles for article (PubMed ID: 1782953)
41. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
42. Contraceptive hormones, vascular risk, and abnormal precipitation of serum gamma-globulins.
Beaumont V; Lemort N; Lorenzelli L; Mosser AM; Beaumont JL
Sem Hop Paris; 1979 Mar 18-25; 55(11-12):5850591. PubMed ID: 12278180
[TBL] [Abstract][Full Text] [Related]
43. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives.
Barnes RW; Krapf T; Hoak JC
Obstet Gynecol; 1978 May; 51(5):556-8. PubMed ID: 652202
[TBL] [Abstract][Full Text] [Related]
44. The oral contraceptive user.
Lidegaard O; Overgaard K; Hauch O
Acta Obstet Gynecol Scand; 1988; 67(1):27-31. PubMed ID: 3176910
[TBL] [Abstract][Full Text] [Related]
45. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Meade TW
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
[TBL] [Abstract][Full Text] [Related]
46. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
47. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
Roy S
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
[TBL] [Abstract][Full Text] [Related]
48. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
[TBL] [Abstract][Full Text] [Related]
49. Variation of ethinylestradiol blood levels among healthy women using oral contraceptives.
Stadel BV; Sternthal PM; Schlesselman JJ; Douglas MB; Hall WD; Kaul L; Ahluwalia B
Fertil Steril; 1980 Mar; 33(3):257-60. PubMed ID: 7364059
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular risks: perception versus reality.
Mishell DR
Contraception; 1999 Jan; 59(1 Suppl):21S-24S. PubMed ID: 10342092
[TBL] [Abstract][Full Text] [Related]
51. Vascular complications in women using the low steroid content combined oral contraceptive pills: case reports and review of the literature.
Frohlich EP
Obstet Gynecol Surv; 1990 Sep; 45(9):578-84. PubMed ID: 2204850
[TBL] [Abstract][Full Text] [Related]
52. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Tanis BC; Rosendaal FR
Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
[TBL] [Abstract][Full Text] [Related]
53. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
54. The risks of oral contraceptives and estrogen replacement therapy.
Coe FL; Parks JH
Perspect Biol Med; 1989; 33(1):86-106. PubMed ID: 2689999
[TBL] [Abstract][Full Text] [Related]
55. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
56. Oral contraceptives and myocardial infarction.
Thorneycroft IH
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1393-7. PubMed ID: 2220964
[TBL] [Abstract][Full Text] [Related]
57. [Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Almer S; Bodemar G; Rydén BO; Elfström J; Franzén L; Ihse I; Resjö M
Lakartidningen; 1989 Nov; 86(46):4002-8. PubMed ID: 2511387
[TBL] [Abstract][Full Text] [Related]
58. The pill and thrombosis: epidemiological considerations.
Carter C
Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):565-85. PubMed ID: 9488792
[TBL] [Abstract][Full Text] [Related]
59. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
de Vries CS; van den Berg PB; de Jong-van den Berg LT
Contraception; 1998 Apr; 57(4):247-9. PubMed ID: 9649916
[TBL] [Abstract][Full Text] [Related]
60. Should the pill be stopped preoperatively?
Sue-Ling H; Hughes LE
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):447-8. PubMed ID: 3126855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
